Cell death induced by acute renal injury: A perspective on the contributions of apoptosis and necrosis

American Journal of Physiology - Renal Physiology

Volumn 284, Issue 4 53-4, 2003, Pages

  Padanilam, Babu J ^a  

^a NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Molecular components; Renal ischemia; Renal tubular epithelial cells; Signal transduction; Therapeutic approaches

Indexed keywords

ENDONUCLEASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; NITRIC OXIDE SYNTHASE; OSTEOPONTIN; PHOSPHOLIPASE; PROTEIN BCL 2; PROTEIN KINASE;

ANIMAL CELL; APOPTOSIS; CELL DEATH; CELL PROLIFERATION; CELL REGENERATION; ENZYME ACTIVATION; HISTOGENESIS; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY TUBULE EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL; TISSUE SPECIFICITY;

EID: 0037376701     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00284.2002     Document Type: Review

References (257)

1. Adams JM and Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322-1326, 1998.
2. Adams JM and Cory S. Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 26: 61-66, 2001.
3. Adrain C and Martin SJ. The mitochondrial apoptosome: a killer unleashed by the cytochrome seas. Trends Biochem Sci 26: 390-397, 2001.
4. Anderson AJ, Stoltzner S, Lai F, Su J, and Nixon RA. Morphological and biochemical assessment of DNA damage and apoptosis in Down syndrome and Alzheimer disease, and effect of postmortem tissue archival on TUNEL. Neurobiol Aging 21: 511-524, 2000.
5. Arendshorst WJ, Finn WF, and Gottschalk CW. Micropuncture study of acute renal failure following temporary renal ischemia in the rat. Kidney Int Suppl 6: S100-S105, 1976.
6. Ashkenazi A and Dixit VM. Death receptors: signaling and modulation. Science 281: 1305-1308, 1998.
7. Avison MJ, van Waarde A, Stromski ME, Gaudio K, and Siegel NJ. Metabolic alterations in the kidney during ischemic acute renal failure. Semin Nephrol 9: 98-101, 1989.
8. Azzarolo AM, Wood RL, Mircheff AK, Richters A, Olsen E, Berkowitz M, Bachmann M, Huang ZM, Zolfagari R, and Warren DW. Androgen influence on lacrimal gland apoptosis, necrosis, and lymphocytic infiltration. Invest Ophthalmol Vis Sci 40: 592-602, 1999.
9. Barros LF, Hermosilla T, and Castro J. Necrotic volume increase and the early physiology of necrosis. Comp Biochem Physiol A Mol Integr Physiol 130: 401-409, 2001.
10. Barros LF, Stutzin A, Calixto A, Catalan M, Castro J, Hetz C, and Hermosilla T. Nonselective cation channels as effectors of free radical-induced rat liver cell necrosis. Hepatology 33: 114-122, 2001.
11. Basile DP, Donohoe D, Roethe K, and Osborn JL. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 281: F887-F899, 2001.
12. Basile DP, Liapis H, and Hammerman MR. Expression of bcl-2 and bax in regenerating rat renal tubules following ischemic injury. Am J Physiol Renal Physiol 272: F640-F647, 1997.
13. Basnakian AG, Ueda N, Kaushal GP, Mikhailova MV, and Shah SV. DNase I-like endonuclease in rat kidney cortex that is activated during ischemia/reperfusion injury. J Am Soc Nephrol 13: 1000-1007, 2002.
14. Beattie MS, Farooqui AA, and Bresnahan JC. Review of current evidence for apoptosis after spinal cord injury. J Neurotrauma 17: 915-925, 2000.
15. Beeri R, Symon Z, Brezis M, Ben-Sasson SA, Baehr PH, Rosen S, and Zager RA. Rapid DNA fragmentation from hypoxia along the thick ascending limb of rat kidneys. Kidney Int 47: 1806-1810, 1995.
16. Bellamy CO, Malcomson RD, Harrison DJ, and Wyllie AH. Cell death in health and disease: the biology and regulation of apoptosis. Semin Cancer Biol 6: 3-16, 1995.
17. Benitez-Bribiesca L, Gomez-Camarillo M, Castellanos-Juarez E, Mravko E, and Sanchez-Suarez P. Morphologic, biochemical and molecular mitochondrial changes during reperfusion phase following brief renal ischemia. Ann NY Acad Sci 926: 165-179, 2000.
18. Berridge MJ, Lipp P, and Bootman MD. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 1: 11-21, 2000.
19. 2. Environ Health Perspect 84: 155-162, 1990.
20. Bonventre JV. Mechanisms of ischemic acute renal failure. Kidney Int 43: 1160-1178, 1993.
21. Bonventre JV. Mediators of ischemic renal injury. Annu Rev Med 39: 531-544, 1988.
22. Bonventre JV and Colvin RB. Adhesion molecules in renal disease. Curr Opin Nephrol Hypertens 5: 254-261, 1996.
23. Brodsky SV, Yamamoto T, Tada T, Kim B, Chen J, Kajiya F, and Goligorsky MS. Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells. Am J Physiol Renal Physiol 282: F1140-F1149, 2002.
24. Brown S, Heinisch I, Ross E, Shaw K, Buckley CD, and Savill J. Apoptosis disables CD31-mediated cell detachment from phagocytes promoting binding and engulfment. Nature 418: 200-203, 2002.
25. Buja LM, Eigenbrodt ML, and Eigenbrodt EH. Apoptosis and necrosis. Basic types and mechanisms of cell death. Arch Pathol Lab Med 117: 1208-1214, 1993.
26. Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 67: 1033-1036, 1991.
27. Carini R, Autelli R, Bellomo G, Dianzani MU, and Albano E. Sodium-mediated cell swelling is associated with irreversible damage in isolated hepatocytes exposed to hypoxia or mitochondrial toxins. Biochem Biophys Res Commun 206: 180-185, 1995.
28. 2+ overload and hepatocyte killing following iron-induced lipid peroxidation. Biochem Biophys Res Commun 208: 813-818, 1995.
29. Carmago S, Shah SV, and Walker PD. Meprin, a brushborder enzyme, plays an important role in hypoxic/ischemic acute renal tubular injury in rats. Kidney Int 61: 959-966, 2002.
30. Chalmers-Redman R, Fraser A, Ju W, Wadia J, Tatton N, and Tatton W. Mechanisms of nerve cell death: apoptosis or necrosis after cerebral ischaemia. Int Reu Neurobiol 40: 1-25, 1997.
31. Chamoun F, Burne M, O'Donnell M, and Rabb H. Pathophysiologic role of selectins and their ligands in ischemia reperfusion injury. Front Biosci 5: E103-E109, 2000.
32. Chao DT and Korsmeyer SJ. BCL-2 family: regulators of cell death. Annu Rev Immunol 16: 395-419, 1998.
33. Cheng Y, Deshmukh M, D'Costa A, Demaro JA, Gidday JM, Shah A, Sun Y, Jacquin MF, Johnson EM, and Holtzman DM. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J Clin Invest 101: 1992-1999, 1998.
34. Chiao H, Kohda Y, McLeroy P, Craig L, Housini I, and Star R. Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J Clin Invest 99: 1165-1172, 1997.
35. Cohen GM, Sun XM, Snowden RT, Dinsdale D, and Skilleter DN. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem J 286: 331-334, 1992.
36. Conger J, Robinette J, Villar A, Raij L, and Shultz P. Increased nitric oxide synthase activity despite lack of response to endothelium-dependent vasodilators in postischemic acute renal failure in rats. J Clin Invest 96: 631-638, 1995.
37. Conger JD and Weil JV. Abnormal vascular function following ischemia-reperfusion injury. J Investig Med 43: 431-442, 1995.
38. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J 341: 233-249, 1999.
39. Cuevas P, Martinez-Coso V, Fu X, Orte L, Reimers D, Gimenez-Gallego G, Forssmann WG, and Saenz De Tejada I. Fibroblast growth factor protects the kidney against ischemia-reperfusion injury. Eur J Med Res 4: 403-410, 1999.
40. Cuttle L, Zhang XJ, Endre ZH, Winterford C, and Gobe GC. Bcl-X(L) translocation in renal tubular epithelial cells in vitro protects distal cells from oxidative stress. Kidney Int 59: 1779-1788, 2001.
41. Daemen MA, Denecker G, van't Veer C, Wolfs TG, Vandenabeele P, and Buurman WA. Activated caspase-1 is not a central mediator of inflammation in the course of ischemiareperfusion. Transplantation 71: 778-784, 2001.
42. Daemen MA, de Vries B, and Buurman WA. Apoptosis and inflammation in renal reperfusion injury. Transplantation 73: 1693-1700, 2002.
43. Daemen MA, van 't Veer C, Denecker G, Heemskerk VH, Wolfs TG, Clauss M, Vandenabeele P, and Buurman WA. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest 104: 541-549, 1999.
44. Dagher P, Modeling ischemia in vitro: selective depletion of adenine and guanine nucleotide pools. Am J Physiol Cell Physiol 279: C1270-C1277, 2000.
45. Dai C, Yang J, and Liu Y. Single injection of naked plasmid encoding hepatocyte growth factor prevents cell death and ameliorates acute renal failure in mice. J Am Soc Nephrol 13: 411-422, 2002.
46. De Broe ME, Apoptosis in acute renal failure. Nephrol Dial Transplant 16: 23-26, 2001.
47. DiMari JF, Davis R, and Safirstein RL. MAPK activation determines renal epithelial cell survival during oxidative injury. Am J Physiol Renal Physiol 277: F195-F203, 1999.
48. DiMari J, Megyesi J, Udvarhelyi N, Price P, Davis R, and Safirstein R. N-acetyl cysteine ameliorates ischemic renal failure. Am J Physiol Renal Physiol 272: F292-F298, 1997.
49. Dong Z, Saikumar P, Weinberg JM, and Venkatachalam MA. Internucleosomal DNA cleavage triggered by plasma membrane damage during necrotic cell death. Involvement of serine but not cysteine proteases. Am J Pathol 151: 1205-1213, 1997.
50. Donnahoo K, Meldrum D, Shenkar R, Chung C, Abraham E, and Harken A. Early renal ischemia, with or without reperfusion, activates NF-κB and increases TNF-α bioactivity in the kidney. J Urol 163: 1328-1332, 2000.
51. Donnahoo K, Shames B, Harken A, and Meldrum D. Review article: the role of tumor necrosis factor in renal ischemiareperfusion injury. J Urol 162: 196-203, 1999.
52. Du C, Fang M, Li Y, Li L, and Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102: 33-42, 2000.
53. Edelstein CL, Ling H, and Schrier RW. The nature of renal cell injury. Kidney Int 51: 1341-1351, 1997.
54. Edelstein CL, Ling H, Wangsiripaisan A, and Schrier RW. Emerging therapies for acute renal failure. Am J Kidney Dis 30: S89-S95, 1997.
55. Edelstein CL, Shi Y, and Schrier RW. Role of caspases in hypoxia-induced necrosis of rat renal proximal tubules. J Am Soc Nephrol 10: 1940-1949, 1999.
56. Eliasson MJ, Sampei K, Mandir AS, Hurn PD, Traystman RJ, Bao J, Pieper A, Wang ZQ, Dawson TM, Snyder SH, and Dawson VL, Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med 3: 1089-1095, 1997.
57. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, and Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391: 43-50, 1998.
58. Endres M, Namura S, Shimizu-Sasamata M, Waeber C, Zhang L, Gomez-Isla T, Hyman BT, and Moskowitz MA. Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. J Cereb Blood Flow Metab 18: 238-247, 1998.
59. Ermak G and Davies KJ. Calcium and oxidative stress: from cell signaling to cell death. Mol Immunol 38: 713-721, 2002.
60. Farber JL, Chien KR, and Mittnacht S Jr. Myocardial ischemia: the pathogenesis of irreversible cell injury in ischemia. Am J Pathol 102: 271-281, 1981.
61. Feldenberg L, Thevananther S, del RM, de LM, and Devarajan P. Partial ATP depletion induces Fas- and caspasemediated apoptosis in MDCK cells. Am J Physiol Renal Physiol 276: F837-F846, 1999.
62. Ferreira CG, Epping M, Kruyt FA, and Giaccone G. Apoptosis: target of cancer therapy. Clin Cancer Res 8: 2024-2034, 2002.
63. Ferri KF and Kroemer G. Organelle-specific initiation of cell death pathways. Nat Cell Biol 3: E255-E263, 2001.
64. 1 cells. Am J Physiol Renal Physiol 277: F428-F436, 1999.
65. Finn WF, Arendshorst WJ, and Gottschalk CW. Pathogenesis of oliguria in acute renal failure. Circ Res 36: 675-681, 1975.
66. Garcia-Calvo M, Peterson EP, Leiting B, Ruel R, Nicholson DW, and Thornberry NA. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J Biol Chem 273: 32608-32613, 1998.
67. Glucksmann A. Cell deaths in normal vertebrate ontogeny. Biol Rev 26: 59-86, 1951.
68. Gobe G, Zhang X, Cuttle L, Pat B, Willgoss D, Hancock J, Barnard R, and Endre R. Bcl-2 genes and growth factors in the pathology of ischaemic acute renal failure. Immunol Cell Biol 77: 279-286, 1999.
69. Goligorsky MS and Noiri E. Duality of nitric oxide in acute renal injury. Semin Nephrol 19: 263-271, 1999.
70. Gross A, Yin XM, Wang K, Wei MC, Jockel J, Milliman C, Erdjument-Bromage H, Tempst P, and Korsmeyer SJ. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J Biol Chem 274: 1156-1163, 1999.
71. Guo K, Searfoss G, Krolikowski D, Pagnoni M, Franks C, Clark K, Yu KT, Jaye M, and Ivashchenko Y. Hypoxia induces the expression of the pro-apoptotic gene BNIP3. Cell Death Differ 8: 367-376, 2001.
72. Ha HC and Snyder SH. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci USA 96: 13978-13982, 1999.
73. Hamburger VRLM. Proliferation, differentiation and degeneration in the spinal ganglia of the chick embryo under normal and experimental conditions. J Exp Zool 111: 457-501, 1975.
74. Hammerman MR. Growth factors and apoptosis in acute renal injury. Curr Opin Nephrol Hypertens 7: 419-424, 1998.
75. Hammerman MR. New treatments for acute renal failure: growth factors and beyond. Curr Opin Nephrol Hypertens 6: 7-9, 1997.
76. Hammerman MR and Miller SB. Growth factor gene expression in tubular epithelial injury. Curr Opin Nephrol Hypertens 4: 258-262, 1995.
77. Hammerman MR and Miller SB. Therapeutic use of growth factors in renal failure. J Am Soc Nephrol 5: 1-11, 1994.
78. Han Z, Hendrickson EA, Bremner TA, and Wyche JH, A sequential two-step mechanism for the production of the mature p17:p12 form of caspase-3 in vitro. J Biol Chem 272: 13432-13436, 1997.
79. 2+-permeable channel activated by changes in redox status confers susceptibility to cell death. Mol Cell 9: 163-173, 2002.
80. Harriman JF, Waters-Williams S, Chu DL, Powers JC, and Schnellmann RG. Efficacy of novel calpain inhibitors in preventing renal cell death. J Pharmacol Exp Ther 294: 1083-1087, 2000.
81. Haunstetter A and Izumo S. Toward antiapoptosis as a new treatment modality. Circ Res 86: 371-376, 2000.
82. Hengartner MO. The biochemistry of apoptosis. Nature 407: 770-776, 2000.
83. 2 in the rat insulinsecreting cell line CRI-G1. J Physiol 501: 59-66, 1997.
84. Herson PS, Lee K, Pinnock RD, Hughes J, and Ashford ML. Hydrogen peroxide induces intracellular calcium overload by activation of a non-selective cation channel in an insulinsecreting cell line. J Biol Chem 274: 833-841, 1999.
85. Horvitz HR, Shaham S, and Hengartner MO. The genetics of programmed cell death in the nematode Caenorhabditis elegans. Cold Spring Harb Symp Syrnp Quant Biol 59: 377-385, 1994.
86. Huang DC and Strasser A. BH3-only proteins-essential initiators of apoptotic cell death. Cell 103: 839-842, 2000.
87. Hwang SM, Lopez CA, Heck DE, Gardner CR, Laskin DL, Laskin JD, and Denhardt DT. Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells. J Biol Chem 269: 711-715, 1994.
88. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, and Tschopp J. Inhibition of death receptor signals by cellular FLIP. Nature 388: 190-195, 1997.
89. Iwata M, Myerson D, Torok-Storb B, and Zager RA. An evaluation of renal tubular DNA laddering in response to oxygen deprivation and oxidant injury. J Am Soc Nephrol 5: 1307-1313, 1994.
90. Jacobs WR, Sgambati M, Gomez G, Vilaro P, Higdon M, Bell PD, and Mandel LJ. Role of cytosolic Ca in renal tubule damage induced by anoxia. Am J Physiol Cell Physiol 260: C545-C554, 1991.
91. Jo SK, Yun SY, Chang KH, Cha DR, Cho WY, Kim HK, and Won NH. α-MSH decreases apoptosis in ischaemic acute renal failure in rats: possible mechanism of this beneficial effect. Nephrol Dial Transplant 16: 1583-1591, 2001.
92. Joza N, Kroemer G, and Penninger JM. Genetic analysis of the mammalian cell death machinery. Trends Genet 18: 142-149, 2002.
93. Joza N, Susin SA, Daugas E, Stanford WL, Cho SK, Li CY, Sasaki T, Elia AJ, Cheng HY, Ravagnan L, Ferri KF, Zamzami N, Wakeham A, Hakem R, Yoshida H, Kong YY, Mak TW, Zuniga-Pflucker JC, Kroemer G, and Penninger JM. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 410: 549-554, 2001.
94. Kaufmann SH and Hengartner MO. Programmed cell death: alive and well in the new millennium. Trends Cell Biol 11: 526-534, 2001.
95. Kaushal GP, Singh AB, and Shah SV. Identification of gene family of caspases in rat kidney and altered expression in ischemia-reperfusion injury. Am J Physiol Renal Physiol 274: F587-F595, 1998.
96. Kaushal GP, Ueda N, and Shah SV. Role of caspases (ICE/ CED 3 proteases) in DNA damage and cell death in response to a mitochondrial inhibitor, antimycin A. Kidney Int 52: 438-445, 1997.
97. Keane RW, Kraydieh S, Lotocki G, Alonso OF, Aldana P, and Dietrich WD. Apoptotic and antiapoptotic mechanisms after traumatic brain injury. J Cereb Blood Flow Metab 21: 1189-1198, 2001.
98. Kelly K, Plotkin Z, and Dagher P. Guanosine supplementation reduces apoptosis and protects renal function in the setting of ischemic injury. J Clin Invest 108: 1291-1298, 2001.
99. Kerr JF. Shrinkage necrosis: a distinct mode of cellular death. J Pathol 105: 13-20, 1971.
100. Kerr JF, Gobe GC, Winterford CM, and Harmon BV. Anatomical methods in cell death. Methods Cell Biol 46: 1-27, 1995.
101. Kerr JF, Wyllie AH, and Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257, 1972.
102. Khan S, Cleveland RP, Koch CJ, and Schelling JR. Hypoxia induces renal tubular epithelial cell apoptosis in chronic renal disease. Lab Invest 79: 1089-1099, 1999.
103. Khan S, Koepke A, Jarad G, Schlessman K, Cleveland RP, Wang B, Konieczkowski M, and Schelling JR. Apoptosis and JNK activation are differentially regulated by Fas expression level in renal tubular epithelial cells. Kidney Int 60: 65-76, 2001.
104. Kim SJ, Lim YT, Kim BS, Cho SI, Woo JS, Jung JS, and Kim YK. Mechanism of reduced GFR in rabbits with ischemic acute renal failure. Ren Fail 22: 129-141, 2000.
105. Koliwad SK, Elliott SJ, and Kunze DL. Oxidized glutathione mediates cation channel activation in calf vascular endothelial cells during oxidant stress. J Physiol 495: 37-49, 1996.
106. Korsmeyer SJ. Regulators of cell death. Trends Genet 11: 101-105, 1995.
107. Kramer AA, Postler G, Salhab KF, Mendez C, Carey LC, and Rabb H. Renal ischemia/reperfusion leads to macrophagemediated increase in pulmonary vascular permeability. Kidney Int 55: 2362-2367, 1999.
108. Kroemer G, Dallaporta B, and Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 60: 619-642, 1998.
109. Kroemer G and Reed JC. Mitochondrial control of cell death. Nat Med 6: 513-519, 2000.
110. Kunduzova OR, Bianchi P, Pizzinat N, Escourrou G, Seguelas MH, Parini A, and Cambon C. Regulation of JNK/ ERK activation, cell apoptosis, and tissue regeneration by monoamine oxidases after renal ischemia-reperfusion. FASEB J 16: 1129-1131, 2002.
111. Kwon O, Phillips CL, and Molitoris BA. Ischemia induces alterations in actin filaments in renal vascular smooth muscle cells. Am J Physiol Renal Physiol 282: F1012-F1019, 2002.
112. Laiho KU, Shelburne JD, and Trump BF. Observations on cell volume, ultrastructure, mitochondrial conformation and vital-dye uptake in Ehrlich ascites tumor cells. Effects of inhibiting energy production and function of the plasma membrane. Am J Pathol 65: 203-230, 1971.
113. Lam TT. The effect of 3-aminobenzamide, an inhibitor of poly-ADP-ribose polymerase, on ischemia/reperfusion damage in rat retina. Res Commun Mol Pathol Pharmacol 95: 241-252, 1997.
114. Lassus P, Opitz-Araya X, and Lazebnik Y. Requirement for caspase-2 in stress-induced apoptosis before mitochondrial per-meabilization. Science 297: 1352-1354, 2002.
115. i/o proteins are involved in adenosine- and ischemic preconditioning-mediated renal protection. J Am Soc Nephrol 12: 233-240, 2001.
116. Leist M and Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2: 589-598, 2001.
117. Leist M, Single B, Kunstle G, Volbracht C, Hentze H, and Nicotera P. Apoptosis in the absence of poly-(ADP-ribose) polymerase. Biochem Biophys Res Commun 233: 518-522, 1997.
118. Lemasters JJV. Necrapoptosis and the mitochondrial permeability transition: shared pathways to necrosis and apoptosis. Am J Physiol Gastrointest Liver Physiol 276: G1-G6, 1999.
119. Lemasters JJ, Qian T, Bradham CA, Brenner DA, Cascio WE, Trost LC, Nishimura Y, Nieminen AL, and Herman B. Mitochondrial dysfunction in the pathogenesis of necrotic and apoptotic cell death. J Bioenerg Biomembr 31: 305-319, 1999.
120. Levitsky J, Gurell D, and Frishman WH. Sodium ion/hydrogen ion exchange inhibition: a new pharmacologic approach to myocardial ischemia and reperfusion injury. J Clin Pharmacol 38: 887-897, 1998.
121. Lewington AJ, Padanilam BJ, Martin DR, and Hammerman MR. Expression of CD44 in kidney after acute ischemic injury in rats. Am J Physiol Regul Integr Comp Physiol 278: R247-R254, 2000.
122. Li G, Segu VB, Rabaglia ME, Luo RH, Kowluru A, and Metz SA. Prolonged depletion of guanosine triphosphate induces death of insulin-secreting cells by apoptosis. Endocrinology 139: 3752-3762, 1998.
123. Li LY, Luo X, and Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412: 95-99, 2001.
124. Li W, Srinivasula SM, Chai J, Li P, Wu JW, Zhang Z, Alnemri ES, and Shi Y. Structural insights into the pro-apoptotic function of mitochondrial serine protease HtrA2/Omi. Nat Struct Biol 9: 436-441, 2002.
125. Lieberthal W. Biology of ischemic and toxic renal tubular cell injury: role of nitric oxide and the inflammatory response. Curr Opin Nephrol Hypertens 7: 289-295, 1998.
126. Lieberthal W, Koh J, and Levine J. Necrosis and apoptosis in acute renal failure. Semin Nephrol 18: 505-518, 1998.
127. Lieberthal W and Levine JS. Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury. Am J Physiol Renal Fluid Electrolyte Physiol 271: F477-F488, 1996.
128. Lieberthal W, Menza SA, and Levine JS. Graded ATP depletion can cause necrosis or apoptosis of cultured mouse proximal tubular cells. Am J Physiol Renal Physiol 274: F315-F327, 1998.
129. Lieberthal W and Nigam SK. Acute renal failure. I. Relative importance of proximal vs. distal tubular injury. Am J Physiol Renal Physiol 275: F623-F631, 1998.
130. Liu X, Rainey JJ, Harriman JF, and Schnellmann RG. Calpains mediate acute renal cell death: role of autolysis and translocation. Am J Physiol Renal Physiol 281: F728-F738, 2001.
131. Liu X, Zou H, Slaughter C, and Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89: 175-184, 1997.
132. Liu Y, Tolbert EM, Lin L, Thursby MA, Sun AM, Nakamura T, and Dworkin LD. Up-regulation of hepatocyte growth factor receptor: an amplification and targeting mechanism for hepatocyte growth factor action in acute renal failure. Kidney Int 55: 442-453, 1999.
133. Lo EH, Bosque-Hamilton P, and Meng W. Inhibition of poly(ADP-ribose) polymerase: reduction of ischemic injury and attenuation of N-methyl-D-aspartate-induced neurotransmitter dysregulation. Stroke 29: 830-836, 1998.
134. Loeffler M and Kroemer G. The mitochondrion in cell death control: certainties and incognita. Exp Cell Res 256: 19-26, 2000.
135. Lorenzo HK, Susin SA, Penninger J, and Kroemer G. Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death. Cell Death Differ 6: 516-524, 1999.
136. Los M, Mozoluk M, Ferrari D, Stepczynska A, Stroh C, Renz A, Herceg Z, Wang ZQ, and Schulze-Osthoff K. Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling. Mol Biol Cell 13: 978-988, 2002.
137. Maeno E, Ishizaki Y, Kanaseki T, Hazama A, and Okada Y. Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis. Proc Natl Acad Sci USA 97: 9487-9492, 2000.
138. Majno G and Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146: 3-15, 1995.
139. Mangili F, Cigala C, and Santambrogio G. Staining apoptosis in paraffin sections. Advantages and limits. Anal Quant Cytol Histol 21: 273-276, 1999.
140. Martin DR, Lewington AJ, Hammerman MR, and Padanilam BJ. Inhibition of poly(ADP-ribose) polymerase attenuates ischemic renal injury in rats. Am J Physiol Regul Integr Comp Physiol 279: R1834-R1840, 2000.
141. Martin LJ. Neuronal cell death in nervous system development, disease, and injury. Int J Mol Med 7: 455-478, 2001.
142. Mason J, Gutsche HU, Moore L, and Muller-Suur R. The early phase of experimental acute renal failure. IV. The diluting ability of the short loops of Henle. Pflügers Arch 379: 11-18, 1979.
143. Masson M, Rolli V, Dantzer F, Trucco C, Schreiber V, Fribourg S, Molinete M, Ruf A, Miranda EA, Niedergang C, Hunting D, Gowans B, Schulz GE, Menissier de Murcia J, and de Murcia G. Poly(ADP-ribose) polymerase: structurefunction relationship. Biochimie 77: 456-461, 1995.
144. Matthys E, Patel Y, Kreisberg J, Stewart JH, and Venkatachalam M. Lipid alterations induced by renal ischemia: pathogenic factor in membrane damage. Kidney Int 26: 153-161, 1984.
145. Meldrum KK, Hile K, Meldrum DR, Crone JA, Gearhart JP, and Burnett AL. Simulated ischemia induces renal tubular cell apoptosis through a nuclear factor-kappaB dependent mechanism. J Urol 168: 248-252, 2002.
146. Meldrum KK, Meldrum DR, Hile KL, Yerkes EB, Ayala A, Cain MP, Rink RC, Casale AJ, and Kaefer MA. p38 MAPK mediates renal tubular cell TNF-alpha production and TNF-alpha-dependent apoptosis during simulated ischemia. Am J Physiol Cell Physiol 281: C563-C570, 2001.
147. Meldrum KK, Meldrum DR, Sezen SF, Crone JK, and Burnett AL. Heat shock prevents simulated ischemia-induced apoptosis in renal tubular cells via a PKC-dependent mechanism. Am J Physiol Regul Integr Comp Physiol 281: R359-R364, 2001.
148. Melnikov V, Ecder T, Fantuzzi G, Siegmund B, Lucia M, Dinarello C, Schrier R, and Edelstein C. Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J Clin Invest 107: 1145-1152, 2001.
149. Mergner W, Jones RT, Trump BJ. Cell Death: Mechanisms of Acute and Lethal Cell Injury. New York: Field and Wood, 1990.
150. Miller SB, Martin DR, Kissane J, and Hammerman MR. Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats. Am J Physiol Renal Fluid Electrolyte Physiol 266: F129-F134, 1994.
151. Miller SB, Martin DR, Kissane J, and Hammerman MR. Rat models for clinical use of insulin-like growth factor I in acute renal failure. Am J Physiol Renal Fluid Electrolyte Physiol 266: F949-F956, 1994.
152. Mirakian R, Nye K, Palazzo FF, Goode AW, and Hammond LJ. Methods for detecting apoptosis in thyroid diseases. J Immunol Methods 265: 161-175, 2002.
153. Molitoris B. Cellular Basis of Ischemic Acute Renal Failure. New York: Churchill Livingstone, 1993.
154. Molitoris BA. Ischemia-induced loss of epithelial polarity: potential role of the actin cytoskeleton. Am J Physiol Renal Fluid Electrolyte Physiol 260: F769-F778, 1991.
155. +-ATPase that redistributes to apical membrane during ATP depletion remains functional. Am J Physiol Renal Fluid Electrolyte Physiol 265: F693-F697, 1993.
156. Molitoris BA. Putting the actin cytoskeleton into perspective: pathophysiology of ischemic alterations. Aro Am J Physiol Renal Physiol 272: F430-F433, 1997.
157. +-ATPase from its surface membrane actin cytoskeletal complex during cellular ATP depletion. J Clin Invest 88: 462-469, 1991.
158. Molitoris BA, Sandoval R, and Sutton TA. Endothelial injury and dysfunction in ischemic acute renal failure. Crit Care Med 30: S235-S240, 2002.
159. Muzio M, Stockwell BR, Stennicke HR, Salvesen GS, and Dixit VM. An induced proximity model for caspase-8 activation. J Biol Chem 273: 2926-2930, 1998.
160. Nadler MJ, Hermosura MC, Inabe K, Perraud AL, Zhu Q, Stokes AJ, Kurosaki T, Kinet JP, Penner R, Scharenberg AM, and Fleig A. LTRPC7 is a Mg ATP-regulated divalent cation channel required for cell viability. Nature 411: 590-595, 2001.
161. Nagata S. Apoptotic DNA fragmentation. Exp Cell Res 256: 12-18, 2000.
162. Nakano K and Vousden KH. PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7: 683-694, 2001.
163. Nicholson DW. From bench to clinic with apoptosis-based therapeutic agents. Nature 407: 810-816, 2000.
164. Nishizuka Y and Nakamura S. Lipid mediators and protein kinase C for intracellular signalling. Clin Exp Pharmacol Physiol Suppl 1: S202-S203, 1995.
165. Nogae S, Miyazaki M, Kobayashi N, Saito T, Abe K, Saito H, Nakane PK, Nakanishi Y, and Koji T. Induction of apoptosis in ischemia-reperfusion model of mouse kidney: possible involvement of Fas. J Am Soc Nephrol 9: 620-631, 1998.
166. Noiri E, Dickman K, Miller F, Romanov G, Romanov VI, Shaw R, Chambers AF, Rittling SR, Denhardt DT, and Goligorsky MS. Reduced tolerance to acute renal ischemia in mice with a targeted disruption of the osteopontin gene. Kidney Int 56: 74-82, 1999.
167. Noiri E, Peresleni T, Miller F, and Goligorsky MS. In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. J Clin Invest 97: 2377-2383, 1996.
168. Nomura M, Shimizu S, Ito T, Narita M, Matsuda H, and Tsujimoto Y. Apoptotic cytosol facilitates Bax translocation to mitochondria that involves cytosolic factor regulated by Bcl-2. Cancer Res 59: 5542-5548, 1999.
169. Okada Y, Maeno E, Shimizu T, Dezaki K, Wang J, and Morishima S. Receptor-mediated control of regulatory volume decrease (RVD) and apoptotic volume decrease (AVD), J Physiol 532: 3-16, 2001.
170. Okusa MD. The inflammatory cascade in acute ischemic renal failure. Nephron 90: 133-138, 2002.
171. + ratio blocks apoptosis in vascular smooth muscle at a site upstream of caspase-3. J Biol Chem 274: 16545-16552, 1999.
172. Ortiz A, Lorz C, and Egido J. The Fas ligand/Fas system in renal injury. Nephrol Dial Transplant 14: 1831-1834, 1999.
173. Padanilam BJ. Induction and subcellular localization of protein kinase C isozymes following renal ischemia. Kidney Int 59: 1789-1797, 2001.
174. Padanilam BJ and Hammerman MR. Ischemia-induced receptor for activated C kinase (RACK1) expression in rat kidneys. Am J Physiol Renal Physiol 272: F160-F166, 1997.
175. Padanilam BJ and Lewington AJ. Molecular mechanisms of cell death and regeneration in acute ischemic renal injury. Curr Opin Nephrol Hypertens 8: 15-19, 1999.
176. Padanilam BJ, Lewington AJ, and Hammerman MR. Expression of CD27 and ischemia/reperfusion-induced expression of its ligand Siva in rat kidneys. Kidney Int 54: 1967-1975, 1998.
177. Padanilam BJ, Martin DR, and Hammerman MR. Insulinlike growth factor 1-enhanced renal expression of osteopontin after acute ischemic injury in rats. Endocrinology 137: 2133-2140, 1996.
178. Park KM, Kramers C, Vayssier-Taussat M, Chen A, and Bonventre JV. Prevention of kidney ischemia/reperfusion-induced functional injury, MAPK and MAPK kinase activation, and inflammation by remote transient ureteral obstruction. J Biol Chem 277: 2040-2049, 2002.
179. Park P, Haas M, Cunningham P, Bao L, Alexander J, and Quigg R. Injury in renal ischemia-reperfusion is independent from immunoglobulins and T lymphocytes. Am J Physiol Renal Physiol 282: F352-F357, 2002.
180. Parrish J, Li L, Klotz K, Ledwich D, Wang X, and Xue D. Mitochondrial endonuclease G is important for apoptosis in C. elegans. Nature 412: 90-94, 2001.
181. Peresleni T, Noiri E, Bahou WF, and Goligorsky MS. Antisense oligodeoxynucleotides to inducible NO synthase rescue epithelial cells from oxidative stress injury. Am J Physiol Renal Fluid Electrolyte Physiol 270: F971-F977, 1996.
182. Perraud AL, Fleig A, Dunn CA, Bagley LA, Launay P, Schmitz C, Stokes AJ, Zhu Q, Bessman MJ, Penner R, Kinet JP, and Scharenberg AM. ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology. Nature 411: 595-599, 2001.
183. Pieper AA, Brat DJ, Krug DK, Watkins CC, Gupta A, Blackshaw S, Verma A, Wang ZQ, and Snyder SH. Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes. Proc Natl Acad Sci USA 96: 3059-3064, 1999.
184. Pieper AA, Verma A, Zhang J, and Snyder SH. Poly (ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol Sci 20: 171-181, 1999.
185. Portilla D. Role of fatty acid beta-oxidation and calciumindependent phospholipase A2 in ischemie acute renal failure, Curr Opin Nephrol Hypertens 8: 473-477, 1999.
186. Portilla D, Shah SV, Lehman PA, and Creer MH. Role of cytosolic calcium-independent plasmalogen-selective phospholipase A2 in hypoxic injury to rabbit proximal tubules. J Clin Invest 93: 1609-1615, 1994.
187. Rabb H, Daniels F, O'Donnell M, Haq M, Saba SR, Keane W, and Tang WW. Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol 279: F525-F531, 2000.
188. Ranganath RM and Nagashree NR. Role of programmed cell death in development. Int Rev Cytol 202: 159-242, 2001.
189. Rao L, Perez D, and White E. Lamin proteolysis facilitates nuclear events during apoptosis. J Cell Biol 135: 1441-1455, 1996.
190. Ravagnan L, Gurbuxani S, Susin SA, Maisse C, Daugas E, Zamzami N, Mak T, Jaattela M, Penninger JM, Garrido C, and Kroemer G. Heat-shock protein 70 antagonizes apoptosis-inducing factor, Nat Cell Biol 3: 839-843, 2001.
191. Reed JC and Kroemer G. Mechanisms of mitochondrial membrane permeabilization (Abstract). Cell Death Differ 7: 1145, 2000.
192. Rich T, Allen RL, and Wyllie AH. Defying death after DNA damage. Nature 407: 777-783, 2000.
193. Roshal M, Zhu Y, and Planelles V. Apoptosis in AIDS. Apoptosis 6: 103-116, 2001.
194. Roy S and Nicholson DW. Programmed cell-death regulation: basic mechanisms and therapeutic opportunities. American Association for Cancer Research Special Conference: Lake Tahoe, CA., USA, 27 February-2 March 2000. Mol Med Today 6: 264-266, 2000.
195. Rudel T and Bokoch GM. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 276: 1571-1574, 1997.
196. Saikumar P, Dong Z, Patel Y, Hall K, Hopfer U, Weinberg JM, and Venkatachalam MA. Role of hypoxia poxia-induced Bax translocation and cytochrome c release in reoxygenation injury. Oncogene 17: 3401-3415, 1998.
197. Saikumar P, Dong Z, Weinberg JM, and Venkatachalam MA. Mechanisms of cell death in hypoxia/reoxygenation injury. Oncogene 17: 3341-3349, 1998.
198. Sakahira H, Takemura Y, and Nagata S. Enzymatic active site of caspase-activated DNase (CAD) and its inhibition by inhibitor of CAD. Arch Biochem Biophys 388: 91-99, 2001.
199. Saunders JW Jr. Death in embryonic systems. Science 154: 604-612, 1966.
200. Savill J. Apoptosis and renal injury. Curr Opin Nephrol Hypertens 4: 263-269, 1995.
201. Scaffidi P, Misteli T, and Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191-195, 2002.
202. Schnellmann RG and Williams SW. Proteases in renal cell death: calpains mediate cell death produced by diverse toxicants. Ren Fail 20: 679-686, 1998.
203. Schulze-Osthoff K, Bakker AC, Vanhaesebroeck B, Beyaert R, Jacob WA, and Fiers W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J Biol Chem 267: 5317-5323, 1992.
204. Schumer M, Colombel MC, Sawczuk IS, Gobe G, Connor J, O'Toole KM, Olsson CA, Wise GJ, and Buttyan R. Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol 140: 831-838, 1992.
205. Schwarz C, Gruber U, and Oberbauer R. Pathophysiology of acute renal failure at the cellular level. Wien Klin Wochenschr 112: 5-15, 2000.
206. Sheridan AM and Bonventre JV. Pathophysiology of ischemic acute renal failure. Contrib Nephrol 132: 7-21, 2001.
207. Shi Y. A conserved tetrapeptide motif: potentiating apoptosis through IAP-binding. Cell Death Differ 9: 93-95, 2002.
208. Shi Y, Melnikov V, Schrier R, and Edelstein C. Downregulation of the calpain inhibitor protein calpastatin by caspases during renal ischemia-reperfusion. Am J Physiol Renal Physiol 279: F509-F517, 2000.
209. Shimizu S, Narita M, and Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399: 483-487, 1999.
210. Smyth PG and Berman SA. Markers of apoptosis: methods for elucidating the mechanism of apoptotic cell death from the nervous system. Biotechniques 32: 648-654, 2002.
211. Somersan S and Bhardwaj N. Tethering and tickling: a new role for the phosphatidylserine receptor. J Cell Biol 155: 501-504, 2001.
212. Strasser A, O'Connor L, and Dixit VM. Apoptosis signaling. Annu Rev Biochem 69: 217-245, 2000.
213. Strasser A, Puthalakath H, Bouillet P, Huang DC, O'Connor L, O'Reilly LA, Cullen L, Cory S, and Adams JM. The role of bim, a proapoptotic BH3-only member of the Bcl-2 family in cell-death control. Ann NY Acad Sci 917: 541-548, 2000.
214. Stromski ME, van Waarde A, Avison MJ, Thulin G, Gaudio KM, Kashgarian M, Shulman RG, and Siegel NJ. Metabolic and functional consequences of inhibiting adenosine deaminase during renal ischemia in rats. J Clin Invest 82: 1694-1699, 1988.
215. Susin SA, Daugas E, Ravagnan L, Samejima K, Zamzami N, Loeffler M, Costantini P, Ferri KF, Irinopoulou T, Prevost MC, Brothers G, Mak TW, Penninger J, Earnshaw WC, and Kroemer G. Two distinct pathways leading to nuclear apoptosis. J Exp Med 192: 571-580, 2000.
216. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, and Kroemer G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397: 441-446, 1999.
217. Suzuki M, Youle RJ, and Tjandra N. Structure of Bax: coregulation of dimer formation and intracellular localization. Cell 103: 645-654, 2000.
218. Takada M, Nadeau KC, Shaw GD, Marquette KA, and Tilney NL. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J Clin Invest 99: 2682-2690, 1997.
219. Thadhani R, Pascual M, and Bonventre JV. Acute renal failure. N Engl J Med 334: 1448-1460, 1996.
220. Thornberry NA. Caspases: a decade of death research. Cell Death Differ 6: 1023-1027, 1999.
221. Thornberry NA and Lazebnik Y. Caspases: enemies within. Science 281: 1312-1316, 1998.
222. Tonshoff B, Kaskel FJ, and Moore LC. Effects of insulinlike growth factor I on the renal juxtamedullary microvasculature. Am J Physiol Renal Physiol 274: F120-F128, 1998.
223. Trachtman H, Valderrama E, Dietrich JM, and Bond JS. The role of meprin A in the pathogenesis of acute renal failure. Biochem Biophys Res Commun 208: 498-505, 1995.
224. Trump BF, Goldblatt PJ, and Stowell RE. Studies of mouse liver necrosis in vitro. Ultrastructural and cytochemical alterations in hepatic parenchymal cell nuclei. Lab Invest 14: 1969-1999, 1965.
225. Trump BF, Goldblatt PJ, and Stowell RE. Studies of necrosis in vitro of mouse hepatic parenchymal cells. Ultrastructural alterations in endoplasmic reticulum, Golgi apparatus, plasma membrane, and lipid droplets. Lab Invest 14: 2000-2028, 1965.
226. Tschopp J, Irmler M, and Thome M. Inhibition of fas death signals by FLIPs. Curr Opin Immunol 10: 552-558, 1998.
227. Tsujimoto Y and Shimizu S. Bcl-2 family: life-or-death switch. FEBS Lett 466: 6-10, 2000.
228. Tsujimoto Y and Shimizu S. VDAC regulation by the Bcl-2 family of proteins. Cell Death Differ 7: 1174-1181, 2000.
229. Ueda N and Shah S. Role of endonucleases in renal tubular epithelial cell injury. Exp Nephrol 8: 8-13, 2000.
230. Vande Velde C, Cizeau J, Dubik D, Alimonti J, Brown T, Israels S, Hakem R, and Greenberg AH. BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol Cell Biol 20: 5454-5468, 2000.
231. Van Why SK and Siegel NJ. Heat shock proteins in renal injury and recovery. Curr Opin Nephrol Hypertens 7: 407-412, 1998.
232. Varfolomeev EE, Schuchmann M, Luria V, Chiannilkulchai N, Beckmann JS, Mett IL, Rebrikov D, Brodianski VM, Kemper OC, Kollet O, Lapidot T, Soffer D, Sobe T, Avraham KB, Goncharov T, Holtmann H, Lonai P, and Wallach D. Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apol, and DR3 and is lethal prenatally. Immunity 9: 267-276, 1998.
233. Vercammen D, Brouckaert G, Denecker G, Van de Craen M, Declercq W, Fiers W, and Vandenabeele P. Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J Exp Med 188: 919-930, 1998.
234. Vetterlein F, Bludau J, Petho-Schramm A, and Schmidt G. Reconstruction of blood flow distribution in the rat kidney during postischemic renal failure. Nephron 66: 208-214, 1994.
235. Vetterlein F, Petho A, and Schmidt G. Distribution of capillary blood flow in rat kidney during postischemic renal failure. Am J Physiol Heart Circ Physiol 251: H510-H519, 1986.
236. Vijayan A, Martin DR, Sadow JL, Kissane J, and Miller SB. Hepatocyte growth factor inhibits apoptosis after ischemic renal injury in rats. Am J Kidney Dis 38: 274-278, 2001.
237. Walker PD, Kaushal GP, and Shah SV. Meprin A, the major matrix degrading enzyme in renal tubules, produces a novel nidogen fragment in vitro and in vivo. Kidney Int 53: 1673-1680, 1998.
238. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, and Boldin MP. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 17: 331-367, 1999.
239. Wang KK. Calpain and caspase: can you tell the difference? Trends Neurosci 23: 20-26, 2000.
240. Wei MC, Lindsten T, Mootha VK, Weiler S, Gross A, Ashiya M, Thompson CB, and Korsmeyer SJ. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev 14: 2060-2071, 2000.
241. Weinberg JM. The cell biology of ischemic renal injury. Kidney Int 39: 476-500, 1991.
242. Weinberg JM, Venkatachalam MA, Roeser NF, and Nissita I. Mitochondrial dysfunction during hypoxia/reoxygenation and its correction by anaerobic metabolism of citric acid cycle intermediates. Proc Natl Acad Sci USA 97: 2826-2831, 2000.
243. Wu X, Molinaro C, Johnson N, and Casiano CA. Secondary necrosis is a source of proteolytically modified forms of specific intracellular autoantigens: implications for systemic autoimmunity. Arthritis Rheum 44: 2642-2652, 2001.
244. Wyllie AH. Death from inside out: an overview. Philos Trans R Soc Lond B Biol Sci 345: 237-241, 1994.
245. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555-556, 1980.
246. Wyllie AH, Kerr JF, and Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 68: 251-306, 1980.
247. 2+ release from the endoplasmic reticulum. Neuron 31: 957-971, 2001.
248. Ye H, Cande C, Stephanou NC, Jiang S, Gurbuxani S, Larochette N, Daugas E, Garrido C, Kroemer G, and Wu H. DNA binding is required for the apoptogenic action of apoptosis inducing factor. Nat Struct Biol 9: 680-684, 2002.
249. Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, Poirier GG, Dawson TM, and Dawson VL. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297: 259-263, 2002.
250. 2-induced cytoprotection of proximal tubules: potential determinants and specificity for ATP depletion-mediated injury. J Am Soc Nephrol 7: 64-72, 1996.
251. Zager RA, Conrad DS, and Burkhart K. Phospholipase A2: a potentially important determinant of adenosine triphosphate levels during hypoxic-reoxygenation tubular injury. J Am Soc Nephrol 7: 2327-2339, 1996.
252. Zamzami N and Kroemer G. The mitochondrion in apoptosis: how Pandora's box opens. Nat Rev Mol Cell Biol 2: 67-71, 2001.
253. Zhang J, Dawson VL, Dawson TM, and Snyder SH. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 263: 687-689, 1994.
254. Zhang J, Liu X, Scherer DC, van Kaer L, Wang X, and Xu M. Resistance to DNA fragmentation and chromatin condensation in mice lacking the DNA fragmentation factor 45. Proc Natl Acad Sci USA 95: 12480-12485, 1998.
255. Zhang J and Xu M. Apoptotic DNA fragmentation and tissue homeostasis. Trends Cell Biol 12: 84-89, 2002.
256. Zhang JH and Xu M. DNA fragmentation in apoptosis. Cell Res 10: 205-211, 2000.
257. Zingarelli B, Cuzzocrea S, Zsengeller Z, Salzman AL, and Szabo C. Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase. Cardiovasc Res 36: 205-215, 1997.